Angelina Sau Man Wong

Title: **Innovative Contributions of Angelina Sau Man Wong in Pharmaceutical Patents**

Introduction

Angelina Sau Man Wong is a prominent inventor based in Redwood City, California, who has made significant contributions in the field of pharmaceuticals. With two patents to her name, her work focuses on innovative compounds that have the potential to revolutionize treatments for various medical conditions.

Latest Patents

Angelina's latest patents include a groundbreaking compound known as N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(R)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide. This compound has been described as an irreversible inhibitor of menin-MLL interactions and showcases multiple crystalline forms and solvates. Furthermore, the patents detail its application in pharmaceutical compositions targeting autoimmune diseases, heteroimmune diseases, cancers (including lymphoma), and various inflammatory conditions.

Career Highlights

Angelina is an inventive force at Biomea Fusion, Inc., where she applies her research expertise to develop innovative treatment options. Her contributions to the field are characterized by a deep understanding of medicinal chemistry and a commitment to improving patient outcomes through innovative therapies.

Collaborations

Throughout her career, Angelina has collaborated with esteemed colleagues, including James T. Palmer and Hongyan He. These collaborations have enhanced her research output and contributed significantly to advancing the science of her patents.

Conclusion

Angelina Sau Man Wong stands out as a remarkable inventor in the pharmaceutical industry. Her contributions not only pave the way for new treatments but also reflect the importance of innovation in addressing complex health challenges. With her ongoing work at Biomea Fusion, Inc., the future looks promising for the advancements she is pioneering in the field of medicine.